#SevenAndI

Highlights of the FY2025 consolidated results and cumulative results for FY2026 Q1, along with full-year guidance. Sales, operating income, and EBITDA for domestic and international CVS segments, segment-by-segment information, capital expenditure, depreciation, and interest-bearing debt are presented, with updates on ratings from agencies such as S&P. Also explains the partial non-consolidation of Seven Bank and the impact of SEGMENT changes.

Details such as the number of shares to be cancelled and the cancellation date are described. It may also reference the total number of issued shares after cancellation.

Capital reserve will be reduced by 350 billion yen and transferred to other capital surplus, resolution scheduled at the general meeting of shareholders on May 27, 2026. The Articles of Incorporation will be amended to allow shareholder meetings without specified location.

At the shareholders meeting scheduled for May 27, 2026, the remuneration limit for directors will be revised to up to JPY 2.5 billion per year, introducing a performance-linked stock compensation system (PSU & RSU). The trust period is planned to be extended from August 1, 2026, to the end of July 2029.

For the fiscal year ending February 2026, consolidated net sales were JPY 10,430.269 billion, operating income was JPY 422.993 billion, and net income attributable to owners of parent was JPY 292.76 billion. Compared to the previous year, net sales decreased to approximately 90.6%, operating income increased to approximately 95.7%, and net income decreased to approximately 92.2%.

Net income attributable to owners of parent for fiscal year 2025 was JPY 292.7 billion, a 169.2% increase year-over-year, with EPS of JPY 118.81. Completed share buyback of JPY 600 billion, rebuilding growth momentum.

Seven & i Holdings Co., Ltd. acquired 16,836,100 shares of treasury stock for 38,939,642,109 yen from February 1 to February 19, 2026, and the acquisition based on the board resolution dated April 9, 2025, has been completed.

Acquired 23,350,600 shares of common stock for 52,126,643,033 yen. The acquisition period was from January 1, 2026 to January 31, 2026.

For the nine months ended Q3 of the fiscal year ending February 2026, consolidated net sales were ¥8,050.937 billion (11.2% decrease YoY), operating income was ¥325.073 billion (3.1% increase YoY), and quarterly net income attributable to owners of parent was ¥198.461 billion (311.9% increase YoY). Treasury stock acquisition amounted to 461,574,000 shares, already completed.

For the cumulative Q3 of FY2026, net sales were JPY 8,050,937 million, 88.8% year-over-year (YoY), operating income was JPY 116,685 million, 90.9% YoY, and net income attributable to owners of parent was JPY 76,659 million, 311.9% YoY.

In Q3 FY2025, operating revenues were ¥8,050.9 billion (99.0% of plan), operating income was ¥325 billion (101.6% of plan), and net income attributable to owners of parent was ¥198.4 billion (106.6% of plan), showing year-over-year increases in both revenue and profit.

Acquired 28,867,700 shares of common stock and a total acquisition amount of ¥62,813,681,435 as treasury stock from December 1, 2025 to December 31, 2025.